Grifols launches FESILTY fibrinogen concentrate in the US Jun 15, 2026 08:02AM
Grifols (GRFS) Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury Oct 22, 2024 08:11AM